Financhill
Back

Rocket Pharmaceuticals Quote, Financials, Valuation and Earnings

Rocket Pharmaceuticals Price Quote

$20.16
-0.01 (-5.62%)
(Updated: September 21, 2024 at 6:40 AM ET)

Rocket Pharmaceuticals Key Stats

Buy
51
Rocket Pharmaceuticals (RCKT) is a Buy

Day range:
$20.11 - $21.29
52-week range:
$16.55 - $32.53
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.77%

Volume:
670.6K
Avg. volume:
734.7K
1-year change:
-8.15%
Market cap:
$1.8B
Revenue:
$0
EPS:
$-2.79

How Much Does Rocket Pharmaceuticals Make?

Data Unavailable

Is Rocket Pharmaceuticals Growing As A Company?

Data Unavailable

Rocket Pharmaceuticals Stock Price Performance

What Is Rocket Pharmaceuticals 52-Week High & Low?

Rocket Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Rocket Pharmaceuticals?

Is Rocket Pharmaceuticals Cash Flow Positive?

  • What Is RCKT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$197.2M
  • What Is Rocket Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $192.6M
  • What Is Rocket Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.9M

Rocket Pharmaceuticals Return On Invested Capital

Data Unavailable

Rocket Pharmaceuticals Earnings Date & Stock Price

Rocket Pharmaceuticals Competitors

Rocket Pharmaceuticals Dividend Yield

Rocket Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -3.16%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 47.15
Upside from Last Price: 133.78%

Major Shareholders

  • How many RCKT shares are owned by institutional investors?
    128.6M RCKT shares are owned by institutional investors
  • How many RCKT shares are owned by insiders?
    1.6M RCKT shares are owned by insiders